Search Within

Nancy Bouvier

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (14)
  3. Research Letter (3)
Groups
  1. Epidemiology and Biostatistics (33)
  2. GSK Faculty (32)
  3. Department of Pathology and Laboratory Medicine (27)
  4. Department of Medicine (26)
  5. Human Oncology and Pathogenesis Program (26)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (24)

More Groups

People
  1. Michael Berger (18)
  2. Andrew Kung (15)
  3. David Solit (12)
  4. Elli Papaemmanuil (12)
  5. Neerav Shukla (11)
  6. Ahmet Zehir (10)

More People

Years
  1. 2023 (4)
  2. 2022 (5)
  3. 2021 (6)
  4. 2020 (3)
  5. 2019 (5)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Research (4)
  3. Cancer Discovery (2)
  4. Neuro-Oncology (2)
  5. Acta Neuropathologica (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (8)
  3. Oxford University Press (4)
  4. Nature Publishing Group (3)
  5. American Society of Hematology (2)
  6. American Medical Association (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic and transcriptomic characterization of papillary microcarcinomas with lateral neck lymph node metastases
    Journal Article

    Perera, D.; Ghossein, R.; Camacho, N.; Senbabaoglu, Y.; Seshan, V.; Li, J.; Bouvier, N.; Boucai, L.; Viale, A.; Socci, N. D.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Tumour lineage shapes BRCA-mediated phenotypes
    Research Letter

    Jonsson, P.; Bandlamudi, C.; Cheng, M. L.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
    Journal Article

    Diolaiti, D.; Dela Cruz, F. S.; Gundem, G.; Bouvier, N.; Boulad, M.; Zhang, Y.; Chou, A. J.; Dunkel, I. J.; Sanghvi, R.; Shah, M.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
    Journal Article

    Teo, M. Y.; Bambury, R. M.; Zabor, E. C.; Jordan, E.; Al-Ahmadie, H.; Boyd, M. E.; Bouvier, N.; Mullane, S. A.; Cha, E. K.; Roper, N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non–muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin
    Journal Article

    Scott, S. N.; Ostrovnaya, I.; Lin, C. M.; Bouvier, N.; Bochner, B. H.; Iyer, G.; Solit, D.; Berger, M. F.; Lin, O.
    Cancer Cytopathology (2017)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save